| Issue Date | Title | Author(s) |
| 2020-08 | The EMT modulator SNAI1 contributes to AML pathogenesis via its interaction with LSD1. | Carmichael, CL; Wang, J; Nguyen, T; Kolawole, O; Benyoucef, A; De Mazière, C; Milne, AR; Samuel, S; Gillinder, K; Hediyeh-Zadeh, S; Vo, ANQ; Huang, Y; Knezevic, K; McInnes, WRL; Shields, BJ; Mitchell, H; Ritchie, ME; Lammens, T; Lintermans, B; Van Vlierberghe, P; Wong, NC; Haigh, K; Thoms, JAI; Toulmin, E; Curtis, DJ; Oxley, EP; Dickins, RA; Beck, D; Perkins, A; McCormack, MP; Davis, MJ; Berx, G; Zuber, J; Pimanda, JE; Kile, BT; Goossens, S; Haigh, JJ |
| 2011-05-23 | An in-silico approach for drug repositioning to tumour anti-migration using an integrated genomic strategy | Mao, Y; Cui, K; Lulu, W; Zhao, H; Nie, F; Brandl, M; Beck, D; Gao, L; Wong, S |
| 2018-12-10 | Lymphocyte-Specific Chromatin Accessibility Pre-determines Glucocorticoid Resistance in Acute Lymphoblastic Leukemia | Jing, D; Huang, Y; Liu, X; Sia, KCS; Zhang, JC; Tai, X; Wang, M; Toscan, CE; McCalmont, H; Evans, K; Mayoh, C; Poulos, RC; Span, M; Mi, J; Zhang, C; Wong, JWH; Beck, D; Pimanda, JE; Lock, RB |
| 2019-11-01 | Ancestry informative markers (AIMs) for Korean and other East Asian and South East Asian populations | Jung, JY; Kang, PW; Kim, E; Chacon, D; Beck, D; McNevin, D |
| 2019-02-26 | HMGA2 promotes long-term engraftment and myeloerythroid differentiation of human hematopoietic stem and progenitor cells | Kumar, P; Beck, D; Galeev, R; Thoms, JAI; Talkhoncheh, MS; de Jong, I; Unnikrishnan, A; Baudet, A; Subramaniam, A; Pimanda, JE; Larsson, J |
| 2019-12-01 | Transcriptional networks in acute myeloid leukemia | Thoms, JAI; Beck, D; Pimanda, JE |
| 2018-10-01 | A novel role for Lyl1 in primitive erythropoiesis | Chiu, SK; Saw, J; Huang, Y; Sonderegger, SE; Wong, NC; Powell, DR; Beck, D; Pimanda, JE; Tremblay, CS; Curtis, DJ |
| 2020-12 | Shwachman-Bodian-Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia. | Dun, MD; Mannan, A; Rigby, CJ; Butler, S; Toop, HD; Beck, D; Connerty, P; Sillar, J; Kahl, RGS; Duchatel, RJ; Germon, Z; Faulkner, S; Chi, M; Skerrett-Byrne, D; Murray, HC; Flanagan, H; Almazi, JG; Hondermarck, H; Nixon, B; De Iuliis, G; Chamberlain, J; Alvaro, F; de Bock, CE; Morris, JC; Enjeti, AK; Verrills, NM |
| 2019-12-09 | A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia | Krivtsov, AV; Evans, K; Gadrey, JY; Eschle, BK; Hatton, C; Uckelmann, HJ; Ross, KN; Perner, F; Olsen, SN; Pritchard, T; McDermott, L; Jones, CD; Jing, D; Braytee, A; Chacon, D; Earley, E; McKeever, BM; Claremon, D; Gifford, AJ; Lee, HJ; Teicher, BA; Pimanda, JE; Beck, D; Perry, JA; Smith, MA; McGeehan, GM; Lock, RB; Armstrong, SA |
| 2014-12-01 | Computational analysis of image-based drug profiling predicts synergistic drug combinations: Applications in triple-negative breast cancer | Brandl, MB; Pasquier, E; Li, F; Beck, D; Zhang, S; Zhao, H; Kavallaris, M; Wong, STC |
